Biomedicine & Advanced Nuclear Medicine (BNCT Tumor Therapy)
Target Clients: Nuclear drug R&D enterprises, BNCT centers in oncology hospitals, biomedical research institutes
Enriched Boric Acid-10
Application: Synthesizes boron-targeted delivery agents for BNCT tumor therapy (e.g., BPA, BSH), functioning as the key upstream precursor raw material for boron neutron capture therapy pharmaceuticals.
Isotope-Enriched Boron-10 (Customizable Elemental/Compound Forms)
Application: Core boron source for clinical BNCT agents. It accumulates selectively within tumor cells and, upon bombardment by external neutron beams, precisely destroys cancerous cells.
Scan to wechat :
Scan to Whatsapp :
home
products
Contact Us